Skip to content

Public FDA record

Z-0496-2018: Hemosphere System with the following three components: HEM1 Advanced Monitor, HEMSGM10 (Swan-Ganz Module)

Recall record Z-0496-2018 for Edwards Lifesciences, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0496-2018
Company in FDA record
Edwards Lifesciences, LLC
FDA classification date
Jan 16, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Pre-procedural issues related to software defects

Source facts

Action
Consignees were sent recall notification letters on approximately 10/11/2017. The letter identified the affected product, problem and actions to be taken. instructions included coordination with the respective Edwards representative to schedule the software upgrade.
Initiated
2017-10-02
Root cause
Device Design
Terminated
2020-12-14
Distribution
US Nationwide Distributed in the states of AZ, CA, CO, GA, IL, MO, NM, OK, OR, SC, TX
Recall number
Z-0496-2018
Recall status
Terminated
CDRH record ID
159598
FDA classified
2018-01-16
Recall event number
78442

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗